惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
T
Tailwind CSS Blog
J
Java Code Geeks
Microsoft Azure Blog
Microsoft Azure Blog
GbyAI
GbyAI
爱范儿
爱范儿
量子位
Martin Fowler
Martin Fowler
V
V2EX
博客园 - 三生石上(FineUI控件)
I
InfoQ
MongoDB | Blog
MongoDB | Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
N
Netflix TechBlog - Medium
D
DataBreaches.Net
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
Last Week in AI
Last Week in AI
U
Unit 42
Apple Machine Learning Research
Apple Machine Learning Research
H
Help Net Security
T
The Blog of Author Tim Ferriss
Hugging Face - Blog
Hugging Face - Blog
美团技术团队
Engineering at Meta
Engineering at Meta

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Baxter International Inc. (BAX) Presents at Bank of Ameri...
2026-05-14 · via All Articles on Seeking Alpha

Baxter International Inc. (BAX) Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDT

Company Participants

Kevin Moran - Vice President & Head of Investor Relations
Andrew Hider - CEO, President, Interim Group President of Medical Products & Therapies and Director

Conference Call Participants

Travis Steed - BofA Securities, Research Division

Presentation

Travis Steed
BofA Securities, Research Division

[Audio Gap] Presentation of the morning. So welcome up next, Baxter International. We are lucky to have Andrew Hider, President and CEO. It's our first time having a fireside chat. So thanks for coming. And then Kevin Moran, VP of Investor Relations. I think you wanted to start out with the legal stuff, Kevin?

Kevin Moran
Vice President & Head of Investor Relations

Yes. Thanks, Travis. Just a reminder, we will be making forward-looking statements today. For more information, please consult our IR website or our SEC filings. Back to you.

Question-and-Answer Session

Travis Steed
BofA Securities, Research Division

Great. Thanks. Andrew, maybe starting out, like your initial time at Baxter, I think you talked about changing the culture to one that's more accountable. Maybe just kind of talk about kind of what kind of changes you've made so far and where you're at in the process?

Andrew Hider
CEO, President, Interim Group President of Medical Products & Therapies and Director

Great. And good morning, everyone. Look, I came to Baxter with a belief around where we sit in the markets, the engagement with our customers and really the ability to get back in line with execution. And if I do a step back, that's only -- my view on the business has continued to evolve, but the thesis around where we sit with our customers, our progress on performance and then ultimately, where we're taking this has been in line.